Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25299193 | 1.00 | IL1B (0.54) | IL1BNLRP3 | |
| SCHEMBL25303047 | 0.93 | IL1B (0.53) | IL1BNLRP3 | |
| SCHEMBL25303044 | 0.93 | IL1B (0.53) | IL1BNLRP3 | |
| SCHEMBL25256910 | 0.91 | IL1B (0.51) | IL1BNLRP3 | |
| SCHEMBL25301955 | 0.91 | IL1B (0.51) | IL1BNLRP3 | |
| SCHEMBL25257343 | 0.91 | IL1B (0.54) | IL1BNLRP3 | |
| SCHEMBL25296235 | 0.91 | IL1B (0.54) | IL1BNLRP3 | |
| SCHEMBL25302439 | 0.90 | NLRP3 (0.54) | IL1BNLRP3 | |
| SCHEMBL25302437 | 0.90 | NLRP3 (0.54) | IL1BNLRP3 | |
| SCHEMBL30833868 | 0.89 | NLRP3 (0.53) | IL1BNLRP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4613749-A1 | NLRP3 INFLAMMASOME INHIBITOR AND USE THEREOF | TransThera Sciences (Nanjing), Inc. (CN) | 2025-09-10 | — | — | EP | disclosed |
| CN-119798221-A | NLRP3 inflammation corpuscle inhibitor and application thereof | 药捷安康(南京)科技股份有限公司 | 2025-04-11 | — | — | CN | disclosed |
| CN-117986258-A | NLRP3 inflammation corpuscle inhibitor and application thereof | 药捷安康(南京)科技股份有限公司 | 2024-05-07 | — | — | CN | disclosed |
| WO-2023131277-A1 | NLRP3 INFLAMMASOME INHIBITOR AND USES THEREOF | 药捷安康(南京)科技股份有限公司 | 2023-07-13 | — | — | WO | disclosed |
| CN-116410140-A | NLRP3 inflammation corpuscle inhibitor and application thereof | 药捷安康(南京)科技股份有限公司 | 2023-07-11 | — | — | CN | disclosed |